Baxter International Inc. Share Price
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | +0.54% | -0.90% | -8.35% |
05-13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
05-10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
Sales 2024 * | 15.11B 1,191B | Sales 2025 * | 15.66B 1,234B | Capitalization | 18.05B 1,423B |
---|---|---|---|---|---|
Net income 2024 * | 703M 55.4B | Net income 2025 * | 950M 74.87B | EV / Sales 2024 * | 1.84 x |
Net Debt 2024 * | 9.7B 765B | Net Debt 2025 * | 8.8B 694B | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
15.8
x | Employees | 60,000 |
Yield 2024 * |
3.37% | Yield 2025 * |
3.49% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | +0.54% | ||
1 week | -0.90% | ||
Current month | -12.24% | ||
1 month | -11.51% | ||
3 months | -13.46% | ||
6 months | +0.34% | ||
Current year | -8.35% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 17/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 05/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 09/05/22 |
Director/Board Member | 64 | 17/02/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 254 M€ | +9.50% | - | |
1.23% | 17 M€ | +8.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 35.43 | +0.54% | 4,906,937 |
14/05/24 | 35.24 | -0.54% | 4,472,962 |
13/05/24 | 35.43 | -0.73% | 4,461,722 |
10/05/24 | 35.69 | -0.72% | 3,962,996 |
09/05/24 | 35.95 | +0.56% | 5,067,955 |
Delayed Quote Nyse, May 15, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.35% | 17.96B | |
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+9.65% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+21.57% | 25.29B |
- Stock Market
- Equities
- BAX Stock